SMA carrier testing: A meta-analysis of differences in test performance by ethnic group

Prenatal Diagnosis

Volumn 34, Issue 12, 2014, Pages 1219-1226

  Macdonald, William Kim ^a   Hamilton, David ^a   Kuhle, Stefan ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLACK PERSON; EMBASE; ETHNIC GROUP; ETHNICITY; GENE DOSAGE; GENE FREQUENCY; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; MUSCLE ATROPHY; PHENOTYPE; POINT MUTATION; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; SCREENING TEST; SPINAL MUSCULAR ATROPHY; SYSTEMATIC REVIEW; WILD TYPE; ETHNOLOGY; GENETICS; HETEROZYGOTE DETECTION;

GENE FREQUENCY; HETEROZYGOTE DETECTION; HUMANS; MUSCULAR ATROPHY, SPINAL;

EID: 84914100077     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4459     Document Type: Article

References (24)

1. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet 2008;371(9630):2120-33.
2. Hendrickson BC, Donohoe C, Akmaev VR, et al. Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet 2009;46(9):641-4.
3. Sugarman EA, Nagan N, Zhu H, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72, 400 specimens. Eur J Hum Genet 2012;20(1):27-32.
4. Muralidharan K, Wilson RB, Ogino S, et al. Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology. J Mol Diagn 2011;13(1):3-6.
5. ACOG Committee on Genetics. ACOG committee opinion No. 432: spinal muscular atrophy. Obstet Gynecol 2009;113(5):1194-6.
6. Prior TW, Professional Practice and Guidelines Committee. Carrier screening for spinal muscular atrophy. Genet Med 2008;10(11):840-2.
7. Wirth B, Herz M, Wetter A, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999;64(5):1340-56.
8. Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4(1):20-6.
9. Prior TW, Nagan N, Sugarman EA, et al. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med 2011;13(7):686-94.
10. Ogino S, Wilson RB, Gold B. New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations. Eur J Hum Genet 2004;12(12):1015-23.
11. R Core Team. 2013. Available at: http://www.R-project.org/ [accessed on 1 July 2014].
12. McAndrew PE, Parsons DW, Simard LR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997;60(6):1411-22.
13. Ogino S, Leonard DG, Rennert H, Wilson RB. Spinal muscular atrophy genetic testing experience at an academic medical center. J Mol Diagn 2002;4(1):53-8.
14. Anhuf D, Eggermann T, Rudnik-Schoneborn S, Zerres K. Determination of SMN1 and SMN2 copy number using TaqMan technology. Hum Mutat 2003;22(1):74-8.
15. Corcia P, Mayeux-Portas V, Khoris J, et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol 2002;51(2):243-6.
16. Cusin V, Clermont O, Gerard B, et al. Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling. J Med Genet 2003;40(4):e39.
17. Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002;70(2):358-68.
18. Chan V, Yip B, Yam I, et al. Carrier incidence for spinal muscular atrophy in southern Chinese. J Neurol 2004;251(9):1089-93.
19. Su YN, Hung CC, Lin SY, et al. Carrier screening for spinal muscular atrophy (SMA) in 107, 611 pregnant women during the period 2005-2009: a prospective population-based cohort study. PLoS One 2011;6(2):e17067.
20. Ben-Shachar S, Orr-Urtreger A, Bardugo E, et al. Large-scale population screening for spinal muscular atrophy: clinical implications. Genet Med 2011;13(2):110-4.
21. Hasanzad M, Azad M, Kahrizi K, et al. Carrier frequency of SMA by quantitative analysis of the SMN1 deletion in the Iranian population. Eur J Neurol 2010;17(1):160-2.
22. Smith M, Calabro V, Chong B, et al. Population screening and cascade testing for carriers of SMA. Eur J Hum Genet 2007;15(7):759-66.
23. Dungan JS. Carrier screening for cystic fibrosis. Obstet Gynecol Clin North Am 2010;37(1):47-59.
24. Little SE, Janakiraman V, Kaimal A, et al. The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol 2010;202(3):253.e1-7.